TherapeuticsAreas HomePage

Therapeutic Areas

Noven’s commercialized products and product development activities are principally focused in the areas of women’s health and mental health, including ADHD and schizophrenia.

Women's Health

Developing and commercializing therapies for women’s menopausal health concerns has been a cornerstone of Noven’s business since it was founded in 1987.

WomensHealth ProductsLPage
MentalHealth ProductsLPage

Mental Health

Noven’s flagship product in the mental health therapeutic category is DAYTRANA® (methylphenidate transdermal system), the first and only transdermal system approved for ADHD in children and adolescents ages 6-17.